Large-scale testing (Phase 3)Study completedNCT00299715
What this trial is testing
Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I Disorder
Who this might be right for
Bipolar DisorderMood Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 473